Details for Patent: 5,354,760
✉ Email this page to a colleague
Summary for Patent: 5,354,760
Title: | Crystalline Tiagabine monohydrate, its preparation and use |
Abstract: | The invention provides crystalline Tiagabine hydrochloride monohydrate, process for its preparation, compositions containing the same and its therapeutic use as anti-epileptic agent. |
Inventor(s): | Petersen; Henning (Lyngby, DK), Nielsen; Peter (Herlev, DK), Cain; Michael (Grayslake, IL), Patel; Subhash (Chicago, IL) |
Assignee: | Novo Nordisk A/S (Bagsvaerd, DK) |
Application Number: | 07/857,038 |
Patent Claim Types: see list of patent claims | Compound; Process; Composition; Use; |
Drugs Protected by US Patent 5,354,760
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 5,354,760
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
Denmark | 0582/91 | Apr 02, 1991 |
International Family Members for US Patent 5,354,760
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 180781 | ⤷ Try a Trial | |||
Australia | 1641592 | ⤷ Try a Trial | |||
Australia | 661483 | ⤷ Try a Trial | |||
Canada | 2107223 | ⤷ Try a Trial | |||
Germany | 69229339 | ⤷ Try a Trial | |||
Denmark | 0579681 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |